![These highlights do not include all the information needed to use REGRANEX® gel safely and effectively. See full prescribing information for REGRANEX gel. REGRANEX (becaplermin) gel, for topical useInitial U.S. Approval: 1997 These highlights do not include all the information needed to use REGRANEX® gel safely and effectively. See full prescribing information for REGRANEX gel. REGRANEX (becaplermin) gel, for topical useInitial U.S. Approval: 1997](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=c080f728-figure-01.jpg&id=407088)
These highlights do not include all the information needed to use REGRANEX® gel safely and effectively. See full prescribing information for REGRANEX gel. REGRANEX (becaplermin) gel, for topical useInitial U.S. Approval: 1997
Integrating the Results of Phase IV (Postmarketing) Clinical Trial With Four Previous Trials Reinforces the Position that Regran
![Wound closure is accelerated by treatment with topical NTX or Regranex... | Download Scientific Diagram Wound closure is accelerated by treatment with topical NTX or Regranex... | Download Scientific Diagram](https://www.researchgate.net/publication/316464020/figure/fig1/AS:540459215921152@1505866926538/Wound-closure-is-accelerated-by-treatment-with-topical-NTX-or-Regranex-O-A-Photographs.png)